{'fraction_non_alphanumeric': 0.014613778705636743, 'fraction_numerical': 0.008350730688935281, 'mean_word_length': 5.666666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Correlation of Securin and Ki67 in Invasive Breast Carcinoma

Apart from skin malignancies, breast cancer ranks the second most common malignancy in females worldwide. The increasing trends of breast cancer have led to plethora of studies in attempt to identify biological markers that may identify patients who may develop local recurrence or metastasis. Among those are proliferation markers which encompass ki67 and Pituitary Derived Tumour‐Transforming Growth Protein (PTTG).